Why the study?
Are circulating concentrations of IrANP(99-126) and IrANP(1-98) associated with cardiovascular, renal, and metabolic diseases in the general population?
Are circulating concentrations of IrANP(99-126) and IrANP(1-98) associated with cardiovascular, renal, and metabolic diseases in the general population?
Measurements of circulating IrANP(99-126) and IrANP(1-98) may provide valuable diagnostic information for congestive heart failure and ischaemic heart disease in elderly populations.
No takes yet. Share an insight, caveat, or question.
May support ANP fragments as age-related biomarkers; leaves open prospective utility beyond established markers.
Wallen et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: